NHS rolls out new 'lifeline' combination therapy for hundreds of women with womb cancer

NHS rolls out new 'lifeline' combination therapy for hundreds of women with womb cancer Hundreds of women with advanced womb cancer in England are to be offered a new ‘lifeline’ option from today, as the NHS rolls out a life-extending new combination therapy that can halt the progression of the disease for twice as long as chemotherapy.

The NHS has agreed landmark commercial deals for two drugs from different manufacturers, which will be used in combination to treat advanced endometrial cancer in between 500 and 750 women each year. NHS England